Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tris(Hydroxyethyl)Aminomethane
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Tris(Hydroxyethyl)Aminomethane, with the chemical formula C7H17NO3 and CAS number 75376-20-4, is an organic compound identified as a pharmaceutical in databases such as ZINC15. While its exact mechanism of action and specific therapeutic indications are not detailed in the available information, its classification as a pharmaceutical suggests potential biological activity. It is important to note that this compound is distinct from Tris(hydroxymethyl)aminomethane (Tromethamine, CAS 77-86-1), which is a well-known buffer used medically for metabolic acidosis, despite the similar nomenclature.
- Other names
- 3-amino-3-(2-hydroxyethyl)pentane-1,5-diol
Beyond the preview
Go deeper on Tris(Hydroxyethyl)Aminomethane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tris(Hydroxyethyl)Aminomethane.